Zydus Lifesciences Ltd
₹921.75
(-0.15%)
Fri, 20 Mar 2026, 08:38 pm
Health Technology
Pharmaceuticals: Major
24.5KZydus Lifesciences Share Price Live Chart
1 Day
0 (0%)
No Result Found
Summary
Market Cap
88181.32
Net Profit
4614.80
P/B
3.72
Sector P/E
32.08
P/E
19.69
EV/EBITDA
12.57
Debt/Equity (Industry)
0.16
Interest Cover (Industry)
17.01
ROCE (Industry)
16.41
RONW (Industry)
14.52
ROE
21.08
ROCE
24.56
Debt/Equity
0.09
EPS (TTM)
50.82
Dividend Yield
1.25
Book Value
251.45
Interest Cover
37.33
Analysis
all
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (3.5x coverage).
- Dividends after 3 years are expected to be well covered by earnings (4.8x coverage).
- Dividends per share have been stable in the past 10 years.
- Cadila Healthcare's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Cadila Healthcare's dividend is below the markets top 25% of dividend payers in India (3.08%).
- Cash flow for Cadila Healthcare is expected to decrease over the next 2 years.
- Cadila Healthcare's net income is expected to increase but not above the 50% threshold in 2 years time.
- Cadila Healthcare is not expected to efficiently use shareholders’ funds in the future (Return on Equity less than 20%).
- Cadila Healthcare's revenue is expected to increase but not above the 50% threshold in 2 years time.
Shareholding
| Shareholders | DEC 2025 | SEPT 2025 | JUN 2025 | MAR 2025 | DEC 2024 |
|---|---|---|---|---|---|
| Promoters | 75.00 | 74.99 | 74.99 | 74.99 | 74.98 |
| FII | 7.06 | 7.34 | 7.13 | 7.32 | 7.53 |
| DII | 11.09 | 10.86 | 11.13 | 11.01 | 10.65 |
| Public | 6.85 | 6.80 | 6.74 | 6.68 | 6.84 |
| Government | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Technical Analysis
Support and Resistance
| Type | R3 | R2 | R1 | PP | S1 | S2 | S3 |
|---|---|---|---|---|---|---|---|
| Classic | 1078.77 | 994.87 | 958.28 | 910.97 | 874.38 | 827.07 | 743.17 |
| Fibonacci | 994.87 | 962.82 | 943.02 | 910.97 | 878.92 | 859.12 | 827.07 |
| Camarilla | 944.77 | 937.08 | 929.39 | 910.97 | 914.01 | 906.32 | 898.63 |
Pivots Level: Classic
R3
+167.80
1078.77
R2
+83.90
994.87
R1
+47.32
958.28
S1
-36.58
874.38
S2
-83.90
827.07
S3
-167.80
743.17
Moving Average
Period
Value
10-EMA
897.52
20-EMA
902.21
30-EMA
903.62
50-EMA
906.93
100-EMA
919.25
200-EMA
934.33
Corporate Actions
| Announcement Date | Purpose | Action | Ex Date |
|---|---|---|---|
| 09 Feb 2026 | board-meetings | Quarterly Results | |
| 06 Nov 2025 | board-meetings | Quarterly Results | |
| 25 Jun 2025 | dividend | Final Dividend - Rs. - 11 | 25 Jul 2025 |
| 20 May 2025 | agm | ||
| 19 May 2025 | dividend | ₹11.00 Dividend /Share | 25 Jul 2025 |
| 26 Jun 2024 | dividend | Final Dividend - Rs. - 3 | 26 Jul 2024 |
| 17 May 2024 | dividend | ₹3.00 Dividend /Share | 26 Jul 2024 |
| 17 May 2024 | agm | ||
| 09 Feb 2024 | buyback | ||
| 23 Jan 2024 | buyback | Buy Back of Shares | 23 Feb 2024 |
Peer Comparison
Zydus Lifesciences Ltd
Lupin Ltd
Divis Laboratories Ltd
Dr Reddys Laboratories Ltd
Torrent Pharmaceuticals Ltd
Sun Pharmaceutical Industries Ltd
Zydus Lifesciences Ltd About
Zydus Lifesciences operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.(Source : 202503-Annual Report Page No:291)
Industry
Pharmaceuticals - Indian - Bulk Drugs & Formln
Founded
1995
Headquarters
CEO
Pankaj R Patel
Employees
Contact
Website
http://www.zyduscadila.com
dhavalsoni@zyduscadila.com; upen.shah@zyduscadila.
Phone
91-079-26868100
Location
Zydus Corporate Park S No 536, Khoraj Sarkhej-Gandhinagar H/W, Ahmedabad, Gujarat, 382481
Zydus Lifesciences Ltd Company History
| Year | History |
|---|---|
| 2020 |
|
| 2021 |
|
| 2022 |
|
| 2023 |
|
| 2024 |
|
Deals
| Client Name | Order Side | QTY | Avg Price | Date |
|---|---|---|---|---|
| UBS PRINCIPAL CAPITAL ASIA LIMITED | Sell | 6701664 | 1128.11 | 30 Aug 2024 |
| INTEGRATED CORE STRATEGIES (ASIA) PTE.LTD. | Buy | 5460159 | 258.21 | 28 May 2019 |
| BLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF | Buy | 7102797 | 403 | 30 Nov 2015 |
| BLACKROCK FUNDS INTERNATIONAL OPPORTUNITIES PORTF | Sell | 555000 | 402.79 | 30 Nov 2015 |
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800